Clinical Trial Update: Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

A Phase 2 efficacy and safety study of JTT-654 in adults with type 2 diabetes has been terminated. The update does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JTT-654 (JTT-654)

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Type II Diabetes Mellitus | Phase 2 | Status: TERMINATED